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Kuldeep K. Bansal,a Deepak Kakde,a Laura Purdie,a Derek J. Irvine,b
Steven M. Howdle,c Giuseppe Mantovania and Cameron Alexander*a
The synthesis of polymers for biomedical applications via environmentally benign routes and with sustain-
able feedstocks is an area of intense interest. Here we describe the synthesis, characterisation and drug
carrier potential of novel polymeric materials obtained from a non-toxic, low cost and easily accessible
renewable monomer, δ-decalactone. A range of diﬀerent polymers and copolymers of δ-decalactone
was synthesised under mild reaction conditions using organic and enzymatic catalysts. Amphiphilic block
copolymers of δ-decalactone with poly(ethyleneglycol) (PEG) and terpolymers with poly(pentadecalac-
tone) were shown to self-assemble into micelles and a hydrophobic dye (Nile Red) was incorporated
inside the micellar cores via a nanoprecipitation method. The encapsulation properties of the polymeric
micelles were explored using Amphotericin B (AmpB) as a model drug. A comparative loading study of
AmpB in PEG-b-poly(δ-decalactone) and in PEG-b-poly(ε-caprolactone) micelles demonstrated a higher
loading of AmpB in the δ-decalactone co-polymer. In vitro release studies of AmpB from the polymer
micelles demonstrated sustained release of AmpB for up to 8 days. A preliminary hydrolytic degradation
and cytotoxicity study indicated that the block co-polymer micelles are biodegradable and exhibit low
toxicity. These data suggest that the δ-decalactone copolymers are of promise for further development
towards biomedical applications.
Introduction
Polymers for drug delivery applications must meet a number
of stringent requirements.1–3 These include very low toxicity,
predictable degradability, compatibility with both active drugs
and excipients, and ‘formulation flexibility’, such that they can
be used in a variety of dosing formats. Increasingly, there are
demands that these materials should be accessible by rapid
and facile synthesis from renewable resources.4–7 This is par-
tially due to future supply constraints for non-biogenic mono-
mers but also a greater desire to include sustainability
throughout the biomedical manufacturing process. New chem-
istries are being devised to generate polymers from non-food-
stock sources, or by novel fermentation and bioengineering
techniques.8–14 Polymers obtained from renewable resources
are already under investigation for drug delivery, and there
have been many examples using natural or modified polysac-
charides and polypeptides. The degradation profiles of these
classes of natural polymers can vary widely dependent on sub-
stituents, and so the polyester backbone has been a major
focus for drug delivery use as the hydrolysis rates are relatively
easy to control. For example, polyesters derived from small
hydrophilic units such as glycerol and citric acid have been
used for gentamicin delivery,15 while the use of sebacoic acid
co-polymerised with glycerol has yielded elastomers suitable
for retinal implants.16
Other polyesters such as poly(lactic acid), (PLA), poly(lactic-
co-glycolic acid) (PLGA), poly(caprolactone) (PCL), are widely
used in biomedical settings but despite their successes, these
polymers still exhibit some undesirable features. PCL is cur-
rently obtained from a non-renewable monomer source,17
while for PLA or PLGA materials, the loading of hydrophobic
drugs has been reported to be low compared to long chain
polyesters.18 Considering these limitations, as well as the
increasing lipophilicity of many candidate drugs emerging
from pharmaceutical screens, there is a real need to develop
more hydrophobic polyester components for drug delivery,
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which can be produced from cheap renewable monomers via
easy synthetic methodologies.19,20
δ-Decalactone, an FDA approved flavouring agent (FDA 21
CFR -172.515) is a candidate monomer for biomedical polymer
applications. This readily available compound is obtained
from the plant Cryptocarya massoia and the ring-opening of
this monomer to synthesise high molar mass poly(δ-decalac-
tone) (PDL) was recently reported.21 The presence of the alkyl
side chain pendant to the polyester backbone in the polymer-
ised δ-decalactone structure is also of potential value in drug
delivery applications. This is because it should generate a
highly hydrophobic core when formulated as a micellar or
nanoparticle delivery system, which may be useful to achieve
better drug loading than is possible with other currently-used
polymers. In addition, the side-chain is expected to disrupt
backbone packing in condensed structures, which might also
favour increased drug incorporation.22,23
In this study, we report the synthesis of novel amphiphilic
block copolymers of δ-decalactone with poly(ethyleneglycol)
(PEG). The reactions were performed under mild conditions in
the absence of solvents as a step towards a metal free “green”
approach to biomedical materials. Homopolymers of δ-deca-
lactone were also synthesised using propargyl alcohol and cis-
1,3-O-benzylideneglycerol (BZD) to introduce model functional
end groups for post polymerisation modification. Further co-
polymers were prepared using a macrolactone (ω-pentadecalac-
tone- an FDA approved flavouring agent/food additive, FDA 21
CFR -172.515) found naturally in angelica root oil, as used
here as a second renewable monomer.24
The micelle-forming properties of the amphiphilic block
copolymers were investigated using Nile red (NR) as a hydro-
phobic dye probe, while the drug loading and release profiles
of the PDL block copolymers were evaluated with Amphoteri-
cin B (AmpB), a broad spectrum antifungal drug of poor
aqueous solubility.
In order to meet primary requirements for biomedical use,
the degradation profiles of the polymers were tested in a pre-
liminary in vitro hydrolysis study, and in vitro cytocompatibility
studies were carried out on human cell lines as a first step to
determine suitability for in vivo use. The Alamar Blue assay
was accordingly used to assess the eﬀects of the co-polymers
on the metabolic activity of HCT-116 cells, a cancer cell line
chosen to represent a likely target for injected co-polymer
formulations.
The monomers and co-polymers evaluated in this work are
shown in Scheme 1.
Experimental section
Materials
δ-Decalactone (≥98%), 1,5,7-triazabicyclo[4.4.0]dec-5-ene
(TBD) (98%), poly(ethyleneglycol) (Mn 4.0 kDa), monomethoxy-
PEG (Mn 5.0 kDa) (mPEG), propargyl alcohol (99%), cis-1,3-O-
benzylideneglycerol (BZD, 97%), benzoic acid (≥99.5%),
ω-pentadecalactone (≥98%), novozymes-435 (≥5000 U g−1,
recombinant, expressed in Aspergillus niger), pyrene (≥99%),
ε-caprolactone (97%), NR (technical grade), AmpB (∼80%),
Tween 80 and RPMI-1640 medium were purchased from Sigma
Aldrich. All solvents were purchased from Fischer Scientific
UK except deuterated solvents and anhydrous toluene, which
were purchased from Sigma Aldrich. Opti-MEM® and Alamar
Blue® were purchased from Life Technologies, UK. PEG and
mPEG were dehydrated by azeotropic distillation using anhy-
drous toluene. δ-Decalactone was passed through basic
alumina before use. Novozymes-435 was dried under vacuum
at 50 °C for 24 hours before use. All other chemicals were used
as received.
Instruments
Fourier transform infrared (FTIR) spectroscopy. FTIR analy-
sis of polymers was performed using a Cary 630 FTIR spectro-
photometer. A small quantity of sample was directly placed on
a clean crystal present in the sample holder. Spectra were pro-
cessed using MicroLab software.
Nuclear magnetic resonance (NMR) spectroscopy. NMR
spectra were recorded using a Bruker NMR spectrometer at
400 MHz (1H) and 101 MHz (13C) in deuterated solvents.
Spectra were analysed using MestReNova 6.0.2 (Mestrelab
Research S.L.) All chemical shifts were recorded in ppm using
the residual solvent peak as an internal standard (CDCl3: δH
7.26, δC 77.16). Molar masses calculated by
1H NMR were used
for calculations of polymer stoichiometries in subsequent
experiments.
Size exclusion chromatography (SEC). The number-average
molar mass (Mn), weight average molar mass (Mw) and mass
distribution (polydispersity, Đ, Mw/Mn) were measured by SEC.
Chromatography was carried out using a Polymer Laboratories
GPC 50 instrument fitted with a diﬀerential refractive index
detector. The eluent was HPLC grade CHCl3 at 30 °C with a
flow rate of 1 mL min−1. The instrument was fitted with a
Polymer Labs PLgel guard column (50 × 7.5 mm, 8 µm) fol-
lowed by a pair of PLgel Mixed-D columns (300 × 7.5 mm,
8 µm). Column calibration was achieved using narrow poly-
styrene standards of known Mn and Đ in the range of 100 Da–
500 kDa. Molar mass and polydispersity were calculated using
Polymer Labs Cirrus 3.0 software.
Diﬀerential scanning calorimetry (DSC). A TA-Q2000 DSC
(TA instruments), was used to determine the melting tempera-
ture (Tm) and glass transition temperature (Tg) of polymers.
Samples (5–15 mg) were weighed into a Tzero DSC pan and
capped with a Tzero DSC lid which was sealed with a Tzero press
(TA instruments) using a black Tzero lower die and a flat upper
die. In a typical run, two cycles of heating and cooling were
carried out: the temperature was increased from (−90) to
200 °C at a rate of 10 °C min−1. The results obtained from the
second cycle were reported.
Particle size and zeta potential measurements
Particle sizes were determined using dynamic light scattering
(DLS) and ζ-potential measurements were performed at 25 °C
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using a Malvern Zetasizer (Nano-ZS) with samples in HPLC
grade water and HEPES 10 mM buﬀer (pH-7.4) respectively.
Data analysis was carried out using the Malvern Zetasizer soft-
ware version 7.03 and mean values obtained from three inde-
pendent measurements were reported.
Transmission electron microscopy (TEM). TEM micro-
graphs were obtained using a Tecnai G2 (FEI, Oregon, USA)
microscope. One drop of polymer solution/suspension in
HPLC grade water (typically 25–50 µg mL−1) was dropped
onto a copper grid and allowed to dry in air. Samples
were imaged on the grids at electron voltages of 100 KV
without staining. TIA imaging software was used for size
evaluation.
Fluorescence spectroscopy. Fluorescence spectra were
recorded on a Cary Eclipse Fluorescence spectrophotometer
(Varian). The fluorescence intensity of samples was measured
against appropriate blank solutions at room temperature. The
excitation and emission slit widths used were 5 nm.
Scheme 1 Schematic representation of the ring opening polymerization of (A) δ-decalactone, (B) ω-pentadecalactone and (C) ε-caprolactone using
diﬀerent initiators to generate ranges of homopolymers and copolymers (RT-room temperature, TBD-1,5,7-triazabicyclo[4.4.0]dec-5-ene).
Paper Polymer Chemistry
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Ultraviolet-visible spectroscopy (UV/Vis). UV-Vis spectra
were recorded using a Beckman Coulter DU 800 UV spectro-
photometer using capped quartz cuvettes. A sample volume
of 700 µl was used for all measurements after appropriate
dilutions.
Synthesis of polymers
Synthesis of δ-decalactone homopolymers. Poly(δ-decalac-
tone) (PDL) was synthesised via ring opening polymerisation
(ROP) of δ-decalactone in bulk according to a reported pro-
cedure.21 The monomer, δ-decalactone (10.00 g, 58.7 mmol),
was transferred into a flask containing an initiating alcohol i.e.
either BZD (0.10 g, 0.6 mmol) or propargyl alcohol (0.03 g,
0.6 mmol) and stirred for 10–15 minutes to make a homo-
geneous mixture. TBD (0.20 g, 1.4 mmol) was then added
under a nitrogen atmosphere and the mixture was allowed
to react for 11 h at the desired temperature (see Table 1,
Scheme 1). The obtained viscous liquid was subsequently
quenched by adding benzoic acid (0.35 g, 2.9 mmol) solution
in acetone, the polymer was precipitated in cold methanol and
the residual solvent was evaporated under vacuum. Polymer
BZD-PDL and propargyl-PDL were recovered as colourless
viscous liquids with yields of 7.90 g (78%) and 7.63 g (76%)
respectively.
BZD-PDL. 1H NMR (400 MHz, CDCl3) δ (ppm) 7.53–7.42
(aromatic–CH, m, 2H), 7.38–7.30 (aromatic–CH, m, 3H), 5.52
(acetal CH, s, 1H), 4.94–4.78 (CH–O–C(O), m, 89H), 4.68 (CH2–
CH̲–O–CO, dd, 1H), 4.31–4.09 (O–CH̲2–CH, m, 4H), 3.64–3.48
(CH2–CH̲–OH ̲, m, 4H), 2.37–2.18 (O–CO–CH2, m, 178H),
1.76–1.38 (CH̲2–CH̲2–CH–CH̲2, m, 535H), 1.27 (CH2̲–CH̲2–CH̲2–
CH3, m, 546H), 0.96–0.76 (CH ̲3, t, 282H).
13C NMR (101 MHz, CDCl3) δ (ppm) 172.98 (CH–O–C̲O,
CH2–CH–O–C̲O), 137.25 (aromatic–C̲–CH–O) 128.98 (aromatic–
CH), 128.19 (aromatic–CH), 125.97 (aromatic–CH), 101.15 (aro-
matic–C–C̲H–O), 73.62 (CH2–C̲H–O–CO, CH2–C ̲H–OH), 71.21
(O–C̲H2–CH), 69.04 (CH2–C̲H–O–CO), 34.14 (CH–C̲H2–CH2),
33.91 (C ̲H2–CH–O–CO, C̲H2–CH–OH), 33.43 (O–CO–C̲H2),
31.60 (C ̲H2–CH2–CH3), 24.89 (CH–CH2–C ̲H2), 22.48 (O–CO–
CH2–C̲H2), 20.77 (C ̲H2–CH3), 13.94 (CH2–C̲H3).
Propargyl-PDL. 1H NMR (400 MHz, CDCl3) δ (ppm)
4.94–4.78 (CH–O–C(O), m, 87H), 4.67 (CH2–O, s, 2H),
3.64–3.48 (CH2–CH̲–OH ̲, m, 4H), 2.48 (CuCH, s, 1H),
2.37–2.18 (O–CO–CH2, m, 174H), 1.76–1.38 (CH ̲2–CH̲2–CH–
CH̲2, m, 522H), 1.38–1.14 (CH̲2–CH̲2–CH̲2–CH3, m, 526H),
0.96–0.76 (CH2–CH̲3, t, 270H).
13C NMR (101 MHz, CDCl3) δ (ppm) 173.04 (CH–O–C̲O,
CH2–O–C̲O), 77.23 (C ̲H–C–CH2), 75.86 (CH–C̲–CH2), 73.69
(CH2–C̲H–O–CO, CH2–C̲H–OH), 34.19 (CH–C̲H2–CH2), 33.94
(C ̲H2–CH–O–CO, C ̲H2–CH–OH), 33.46 (O–CO–C̲H2), 31.64
(C ̲H2–CH2–CH3), 24.93 (CH–CH2–C ̲H2), 22.52 (O–CO–CH2–
C̲H2), 20.79 (C̲H2–CH3), 13.98 (CH2–C̲H3).
Synthesis of block copolymers of δ-decalactone. A di-block
(AB type) copolymer of δ-decalactone was synthesised using
mPEG as initiator. MethoxyPEG (5.0 kDa, 11.20 g, 2.2 mmol)
was added in a flask containing δ-decalactone (57.20 g,
336.0 mmol) and the mixture was heated to 50 °C and stirred
for 10 minutes, until a homogeneous mixture was obtained.
TBD (1.17 g, 8.4 mmol) was added and the mixture was
allowed to react for 7 hours at 50 °C. The reaction mixture was
then cooled, quenched by adding benzoic acid (2.05 g,
16.8 mmol) solution in acetone (4 mL) and the resulting
polymer was precipitated in cold methanol followed by
removal of residual solvent in vacuum. The obtained dry
material was dissolved in a minimum quantity of acetone and
re-precipitated in petroleum ether. Any residual solvent was
evaporated under vacuum to yield the desired copolymer. A
similar procedure was followed to synthesise a tri-block (PDL-
b-PEG-b-PDL, ABA type) copolymer of δ-decalactone (4.25 g,
25.0 mmol) using PEG (1.0 g, 0.3 mmol) as initiator (see
Table 1). Copolymers mPEG-b-PDL and PDL-b-PEG-b-PDL were
recovered as wax-like materials with yields of 46.24 g (67%)
and 3.66 g (70%), respectively.
mPEG-b-PDL. 1H NMR (400 MHz, CDCl3) δ (ppm) 4.95–4.84
(CH–O–CO, m, 37H), 4.27–4.17 (CH2–O–CO, t, 2H), 3.65
(O–CH2–CH2–O, s, 497H), 3.38 (O–CH3, s, 3H), 2.32 (O–CO–
CH2, m, 75H), 1.75–1.40 (CH̲2–CH̲2–CH–CH̲2, m, 222H),
1.39–1.18 (CH ̲2–CH̲2–CH̲2–CH3, m, 227H), 0.95–0.77 (CH2–
CH̲3, t, 138H).
13C NMR (101 MHz, CDCl3) δ (ppm) 173.04 (CH–O–C̲O,
CH2–O–C̲O), 73.67 (CH2–C̲H–O–CO, CH2–C̲H–OH), 70.57
(CH2–CH2–O), 65.96 (C ̲H2–O–CO) 57.86 (O–CH3), 34.19
(CH–C̲H2–CH2), 33.94 (C ̲H2–CH–O–CO, C̲H2–CH–OH), 33.47
(O–CO–C̲H2), 31.64 (C ̲H2–CH2–CH3), 24.93 (CH–CH2–C̲H2),
22.52 (O–CO–CH2–C̲H2), 20.80 (C̲H2–CH3), 13.99 (CH2–C̲H3).
Table 1 Summary of experimental details and characterisation data obtained after ROP of δ-decalactone, *ε-caprolactone and $ω-pentadecalac-
tone. (M/I –monomer to initiator ratio, NM – not measured, ND – not detected, RT – room temperature)
Run Initiator
M/I
ratio
Temperature
(°C)
Time
(h)
Catalyst
(mol%)
Conversion
NMR (%)
Mn,NMR
(kDa)
Mn,SEC
(kDa)
Đ
(Mw/Mn)
Tg
(°C)
Tm
(°C)
1 cis-1,3-O-Benzylidene glycerol 100 5 11 2.5 89 15.3 8.8 1.21 NM NM
2 Propargyl alcohol 100 RT 11 2.5 87 14.8 7.5 1.18 −54.2 ND
3 Poly(ethylene glycol) 150 40 8 2.5 89 10.3 16.2 1.15 −53.3 47.0
4 Poly(ethylene glycol) methyl
ether
150 50 7 2.5 91 11.3 19.5 1.17 −54.6 54.6
5* Poly(ethylene glycol) methyl
ether
52 110 0.17 2.0 99 10.7 19.3 1.31 NM NM
6$ mPEG-b-PDL 12 70 3 10.0 ( wt%) 98 12.9 21.8 1.25 −52.7 54.7, 88.0
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FTIR ν (cm−1): 2858 (C–H, stretching), 1729 (CvO, stretch-
ing), 1341 (C–H, bending), 1106 (C–O, Stretching).
PDL-b-PEG-b-PDL. 1H NMR (400 MHz, CDCl3) δ (ppm)
4.97–4.80 (CH–O–CO, m, 37H), 4.24 (CH2–O–CO, t, 4H), 3.66
(O–CH2–CH2–O, s, 409H), 2.41–2.18 (O–CO–CH2, m, 78H),
1.75–1.39 (CH̲2–CH̲2–CH–CH̲2, m, 218H), 1.37–1.12 (CH ̲2–CH̲2–
CH̲2–CH3, m, 226H), 0.97–0.77 (CH2–CH̲3, t, 140H).
13C NMR (101 MHz, CDCl3) δ (ppm) 173.05 (CH–O–C̲O,
CH2–O–C̲O), 73.70 (CH2–C̲H–O–CO, CH2–C̲H–OH), 70.56
(CH2–CH2–O), 64.11 (C ̲H2–O–CO), 34.20 (CH–C ̲H2–CH2), 33.94
(C ̲H2–CH–O–CO, C ̲H2–CH–OH), 33.47 (O–CO–C̲H2), 31.65
(C ̲H2–CH2–CH3), 24.95 (CH–CH2–C ̲H2), 22.52 (O–CO–CH2–
C̲H2), 20.79 (C̲H2–CH3), 13.99 (CH2–C̲H3).
Synthesis of methoxy(poly(ethyleneglycol))-b-poly(caprolac-
tone) (mPEG-b-PCL). A di-block (AB type) copolymer of
ε-caprolactone was synthesised as a polymer analogue for the
PDL block co-polymers, using mPEG as the initiator and TBD
as the catalyst. Briefly, mPEG (6.00 g, 1.2 mmol) was added in
a flask containing ε-caprolactone (7.00 g, 61.3 mmol), heated
to 110 °C under a nitrogen atmosphere and stirred for
10 minutes until a homogeneous mixture was obtained. TBD
(0.17 g, 1.2 mmol) was dissolved in 500 µl of anhydrous
acetone and added to the mixture via syringe and reaction was
continued for 10 minutes under a nitrogen atmosphere. The
reaction mixture was cooled to room temperature, quenched
by addition of benzoic acid (0.29 g, 2.4 mmol) solution in
acetone (0.5 mL) and the resultant polymer was precipitated in
cold methanol followed by precipitation in diethyl ether. The
residual solvent was evaporated under vacuum to obtain the
purified material. Copolymer mPEG-b-PCL was recovered as an
oﬀ-white powder (12.20 g, 94%).
1H NMR (400 MHz, CDCl3) δ (ppm) 4.24 (CH2–O–CO, t,
2H), 4.07 (CH2–O–CO, t, 100H), 3.66 (O–CH2–CH2–O, s, 522H),
3.40 (O–CH3, s, 3H), 2.33 (O–CO–CH̲2, t, 100H), 1.74–1.58
(CH ̲2–CH2–CH̲2, m, 200H), 1.46–1.32 (CH2–CH̲2–CH2, m,
100H).
13C NMR (101 MHz, CDCl3) δ (ppm) 173.51 (CH2–O–C̲O),
70.57 (CH2–CH2–O), 64.13 (C ̲H2–O–CO), 57.69 (O–CH3), 34.11
(O–CO–C̲H2), 28.35 (CH2–CH2–C̲H2), 25.52 (CH2–C̲H2–CH2),
24.57 (C ̲H2–CH2–CH2).
Synthesis of methoxy(poly(ethyleneglycol))-b-poly(decalac-
tone)-b-poly(pentadecalactone) (mPEG-b-PDL-b-PPDL). A co-
polymer of ω-pentadecalactone was synthesised using mPEG-b-
PDL as the initiator via a reported procedure25 with slight
modifications. The starting copolymer, mPEG-b-PDL (2.90 g,
0.3 mmol) and ω-pentadecalactone (0.75 g, 3.1 mmol) was dis-
solved in anhydrous toluene (10 mL) and transferred into a
flask containing Novozyme-435 (0.08 g, 10% by weight of
ω-pentadecalactone). The reaction mixture was heated to 70 °C
and allowed to react for 3 hours, cooled to room temperature,
and an excess of cold acetone (60 mL) was added. The reaction
mixture was then filtered to remove the catalyst, and concen-
trated to a volume of ∼30 mL. The solution was again filtered
to remove insoluble polymer impurities (high molecular
weight copolymer and/or poly(pentadecalactone) (PPDL)
homopolymer). The filtrate was then concentrated and precipi-
tated in cold methanol to remove any unconverted ω-penta-
decalactone monomer, followed by drying under reduced
pressure. Copolymer mPEG-b-PDL-b-PPDL was isolated as a
colourless solid (2.24 g, 61%).
1H NMR (400 MHz, CDCl3) δ (ppm) 4.88 (CH–O–CO, m,
38H), 4.28–4.17 (CH2–O–CO, t, 2H), 4.08 (CH2–O–CO, m, 14H),
3.66 (O–CH2–CH2–O, s, 505H), 3.39 (O–CH3, s, 3H), 2.32 (O–
CO–CH2, m, 92H), 1.77–1.42 (CH̲2–CH̲2–CH–CH̲2, O–CO–CH2–
CH̲2, m, 243H), 1.28 (CH̲2–CH̲2–CH̲2–CH3, CH2–CH2, m,
374H), 0.88 (CH2–CH̲3, t, 121H).
13C NMR (101 MHz, CDCl3) δ (ppm) 173.98 (CH–O–C̲O–
CH2), 173.03 (CH–O–C ̲O), 73.68 (CH2–C̲H–O–CO), 70.56 (CH2–
CH2–O), 64.38 (C ̲H2–O–CO), 58.58 (O–CH3), 34.40 (O–CO–C̲H2),
34.19 (CH–C̲H2–CH2), 33.94 (C ̲H2–CH–O–CO), 33.46 (O–CO–
C̲H2), 31.64 (C̲H2–CH2–CH3), 29.77–29.00 (pentadecalactone–
CH2), 28.65 (pentadecalactone–CH2), 25.93 (pentadecalac-
tone–CH2), 24.98 (CH–CH2–C̲H2, pentadecalactone–CH2),
22.51 (O–CO–CH2–C̲H2), 20.81 (C̲H2–CH3), 13.98 (CH2–C̲H3).
Determination of CMC of PDL and PCL block copolymer
micelles
The CMC of block copolymers of PDL (i.e. mPEG-b-PDL, PDL-
b-PEG-b-PDL and mPEG-b-PDL-b-PPDL) and PCL (i.e. mPEG-b-
PCL) were determined via a reported method with slight modi-
fication.26 A 6 × 10−7 M stock solution of pyrene in acetone was
prepared and a pre-calculated quantity of pyrene was trans-
ferred into vials followed by evaporation of acetone under a
slow stream of nitrogen. Diﬀerent concentrations (from 0.001
to 50 µg mL−1) of polymer solutions in water were then added
to each vial and left overnight (in the dark) with agitation to
equilibrate. Fluorescence spectra of solutions were recorded in
the range of 350 to 420 nm at an excitation wavelength of
335 nm. The intensities of emitted light at 373 nm (I1) and
384 nm (I3) were used to calculate the pyrene 1 : 3 ratio and
plotted against the concentration of polymer used (log scale).
All measurements were carried out in triplicate at 25.0 ± 1 °C
and mean values were reported. The data were analysed using
GraphPad Prism software (version 6.4).
Empty and dye loaded micelles preparation from PDL and
PCL block copolymers
Micelles of synthesised block copolymers were prepared by a
single-step nano-precipitation method with minor modifi-
cation.27,28 A PDL or PCL block copolymer (50 mg) was dis-
solved in acetone (5 mL) and this solution was added drop-
wise into 10 mL of HPLC grade water under stirring (1000
rpm). The solution was then stirred for 3 hours at room tem-
perature and left overnight (open vial, without stirring) to
ensure the complete removal of acetone. Dye-loaded PDL block
copolymer micelles were prepared by a similar method in
which NR (1.0 mg) was dissolved along with the polymer
(50 mg) in acetone (5 mL). The micellar solution was then fil-
tered through a membrane syringe filter (pore size: 0.22 μm)
(Millex-LG, Millipore Co., USA) and used for further character-
isation. A portion of the dye loaded micelles was freeze dried
for the determination of dye content and encapsulation
Paper Polymer Chemistry
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eﬃciency (EE). Dye content was determined by dissolving a
known amount of freeze dried micelles (5.0 mg) in acetone fol-
lowed by quantification of NR content by UV-Vis spectropho-
tometry at λmax = 541 nm. The concentration of NR in samples
was calculated using a NR standard calibration curve.
Preparation of nano-emulsion from PDL homopolymer
An end-functional homopolymer of PDL i.e. propargyl-PDL was
used to make an oil-in-water nanoemulsion for comparative
studies with blank micelles. The nano-emulsion formulation
was prepared by following the same procedure used to prepare
blank micelles. This method resulted in the rapid formation of
dispersed droplets of propargyl-PDL in water.
Preparation and characterisation of blank and AmpB loaded
micelles
Empty and AmpB loaded micelles of mPEG-b-PDL and mPEG-
b-PCL (50.0 mg each) were fabricated by nanoprecipitation as
described above, but using methanol (5 mL) as an organic
solvent to solubilise polymer and drug instead of acetone. The
initial amount of AmpB used for the encapsulation study was
2.0 mg. During the drug content determination procedure,
redissolution of lyophilised mPEG-b-PCL micelles in methanol
resulted in the formation of a small amount of insoluble
residue. Samples were therefore sonicated for 2 minutes and
then centrifuged (2 minutes) at 5000 rpm to remove any
residual precipitate. An identical method was followed for lyo-
philised mPEG-b-PDL micelles. Supernatant (methanol) was
collected from each sample and analysed at λmax = 405 nm by
UV-Vis spectrophotometry. The amount of AmpB was then cal-
culated using a standard calibration curve for AmpB in
methanol.
In vitro release study of AmpB from block copolymer micelles
An in vitro release study was performed in modified release
media i.e. water containing Tween 80 (1% v/v) to facilitate the
solubilisation of AmpB.29 A calculated amount of AmpB-
loaded freeze-dried micelles, equivalent to 200 µg of AmpB
was redispersed in HPLC grade water (2 mL). The solution was
then placed in dialysis tubing (Slide-A-Lyzer, 3.5 kDa molar
mass cut-oﬀ, Thermo Scientific) and dialysed against 10 mL of
release media at 37 °C. The whole release media were replaced
with fresh media at predetermined time intervals to maintain
sink conditions. Collected release media (samples) were then
freeze dried. The dried samples were dissolved in methanol
(1 mL) and analysed via UV-Vis spectrophotometry at λ =
405 nm. The amount of AmpB in samples was then calculated
using a standard calibration curve of AmpB in methanol (con-
taining 10% v/v of Tween 80). A control sample was prepared
by dissolving 200 µg of AmpB in 2 mL of water (containing 2%
v/v of Tween 80) (control “A”). An additional control experi-
ment was also carried out by adding 50 µl of mPEG-b-PDL
copolymer solution in acetone (100 mg of mPEG-b-PDL in
1 mL of acetone) to the control “A” solution. The solution was
then bubbled with nitrogen to remove acetone and volume was
made up to 2 mL using water, if required. This sample was
named control “B”. The AmpB release profile for control
samples was analysed by following the same method used for
mPEG-b-PDL micelles.
In vitro degradation study of mPEG-b-PDL micelles
The degradation profile of empty mPEG-b-PDL micelles was
assessed at two diﬀerent pH values, pH 7.4 (to model normal
body fluid conditions) and pH 4.0 (to simulate acidic build-up
during bulk degradation) at 37 °C. Freeze dried empty micelles
(8 mg) samples were redispersed in 1 mL of acetate buﬀer (pH
4.0, 10 mM) and phosphate buﬀer (pH 7.4, 10 mM) separately.
The samples were then incubated at 37 °C under agitation in a
water bath. At predetermined time intervals, one sample vial
from each pH was collected and freeze-dried. The freeze-dried
samples were then dissolved in chloroform, filtered and ana-
lysed by SEC to determine the change in polymer average
molar mass (Mn).
In vitro cytocompatibility study of mPEG-b-PDL and
mPEG-b-PCL micelles
HCT116 cells were obtained from ATCC. Cells were routinely
maintained in RPMI-1640 medium supplemented with 10%
FBS and 2 mM L-glutamine at 37 °C 5% CO2. The cells were
seeded at 10 000 cells per well in 96 well plates and after
48 hours, the complete medium was replaced with 200 µl Opti-
MEM® (Life Technologies). Stock solutions of micelles (5 mg
mL−1) were diluted to 3.33, 1.67 and 0.83 mg mL−1 in sterile
distilled water (dH2O). To each well, 15 µl of the appropriate
micelle dilution or dH2O was added to give final concen-
trations of 349, 232.5, 116, 58 and 0 µg mL−1. After 24 hours
incubation at 37 °C, an Alamar Blue assay (Life Technologies)
was conducted according to the manufacturer’s instructions.
After 1 hour incubation, the fluorescence from each well was
measured using a Molecular Devices Flexstation 3 plate reader
(λex = 585 nm, λem = 610 nm). The metabolic activities of the
cells were reported relative to untreated cells (100% viability).
A one-way ANOVA with Tukey’s multiple comparison test was
conducted for the 349 µg mL−1 sample using GraphPad Prism
6 software.
Results
Synthesis and characterisation of δ-decalactone
homopolymers
The synthetic route for synthesis of PDL homopolymers is
shown in Scheme 1A. The ROP of δ-decalactone was performed
at either 5 °C or room temperature to generate homopolymers
with terminal functionality. Conversion was monitored by 1H
NMR, by comparing the integral of the CH ester peak at
4.3 ppm of the cyclic monomer (Fig. S1,† peak e), and the
corresponding CH signal of the PDL polymer, at 4.9 ppm
(Fig. S2,† peak d). Polymerisations were stopped by blocking
the organo-catalyst with benzoic acid, followed by precipitation
in cold methanol, which removed the unconverted monomer
and inactivated catalyst (Fig. S3†). Purified polymer was iso-
Polymer Chemistry Paper
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lated by centrifugation, and traces of solvent were removed
under vacuum. The obtained δ-decalactone homopolymers
were amorphous, and therefore no Tm could be observed in
DSC analysis, while the Tg of the polymer was measured for
propargyl-PDL and found to be ∼−54 °C (Table 1, Fig. S4†). 1H
NMR spectra of the synthesised polymers with assigned peaks
are shown in Fig. S2.† Proton integration of peaks at 4.9 ppm
and 4.67 ppm (for propargyl-PDL), or 5.52 and 4.68 ppm (for
BZD-PDL) were used to calculate the average molar mass of
polymer (Mn,NMR).
13C NMR spectra were also acquired to
characterise the PDL polymers (Fig. S5†). The NMR spectra for
the PDL homopolymers were in line with literature data,21
although it was also found that for as-prepared polymers, the
integral of the CH–OH end-group proton resonance at 3.5 ppm
in 1H NMR was higher than the expected value.
SEC using chloroform as the mobile phase gave a unimodal
size distribution with relatively narrow polydispersity for
both homopolymers. However, the Mn observed by SEC was
lower than the molar mass calculated by 1H NMR (Table 1,
Fig. S6†).
Synthesis and characterisation of δ-decalactone block
copolymers
Block copolymers of δ-decalactone were synthesised at a tem-
perature above the melting point of PEG to avoid the use of
added solvents in the reaction (Scheme 1A, Table 1). The target
molar mass of PDL chain for both copolymers was 5 kDa. It
was observed that increases in the catalyst loading accelerated
the conversion of monomer to polymer. Reaction rates were
monitored by 1H NMR and the acquired data suggested that
the reaction followed first order kinetics (Fig. S7†).
As noted above, homopolymer formation was observed
from the beginning of the reaction (Fig. S8, Table S1†),
suggesting a competing initiator for ROP, either residual
moisture or traces of ring-opened decalactone from monomer
hydrolysis. The undesired PDL homopolymer was separated
from block copolymers by washing the reaction mixture with
excess petroleum ether (2–3 times). FTIR, 1H NMR and 13C
NMR spectra of the synthesised block copolymers with
assigned peaks are shown in Fig. S9, S10 and S11† respectively.
Molar masses were calculated from 1H NMR spectra by com-
paring the number of protons adjacent to the PDL ester
linkage at 4.9 ppm with respect to protons of initiator (PEG) at
3.6 (3.3 ppm in the case of mPEG) and the protons adjacent to
the ester bond created after ring opening of δ-decalactone by
PEG-OH at 4.2 ppm.
Both copolymers showed essentially unimodal distributions
in SEC traces however, some tailing was detected for mPEG-b-
PDL (Fig. S12†), which may have been due to the presence of
residual free mPEG. Synthesised copolymers were also charac-
terised by DSC to determine the change in thermal properties.
The block copolymers showed the expected Tm corresponding
to PEG, as well as a low Tg attributed to amorphous PDL
(Fig. S13†). The Mn detected by SEC, molar mass by NMR,
Tg, Tm and other experimental details are summarised in
Table 1.
Synthesis and characterisation of mPEG-b-PDL-b-PPDL
A schematic representation of the synthesis of block copoly-
mers of ω-pentadecalactone, using mPEG-b-PDL as initiator, is
shown in Scheme 1B. The conversion of monomer to copoly-
mer (mPEG-b-PDL-b-PPDL) was monitored by 1H NMR in
which the appearance of a resonance at 4.08 ppm suggested
the successful ROP of ω-pentadecalactone. No changes in peak
positions of mPEG-b-PDL in 1H NMR spectrum were observed
after growth of the PPDL block. The physical state of the
polymer was changed from a waxy material (mPEG-b-PDL) to a
sticky solid (mPEG-b-PDL-b-PPDL). The 1HNMR spectrum of
the purified copolymer was obtained in chloroform-d and the
peak positions of the PPDL block matched those reported pre-
viously25 (Fig. S14†). Integrals of methylene protons in 1H
NMR at 4.0, 4.8 and 3.3 ppm were used to calculate the molar
mass, which was found to be 12.9 kDa, compared to Mn
21.8 kDa with Mw/Mn (Đ) of 1.25 obtained by SEC (Table 1).
This block copolymer was further characterized by 13C NMR
and DSC to confirm the structure and to determine the eﬀect
on thermal properties due to the presence of the PPDL block.
Peak positions of the PPDL block in 13C NMR spectra also
matched the previously reported values25 (Fig. S14†). The Tg of
mPEG-b-PDL-b-PPDL copolymer did not change when com-
pared to mPEG-b-PDL however the graph showed two distinct
melting peaks which corresponded to the individual PEG and
PPDL blocks (Fig. S15†).
The melting temperature observed for the PPDL block was
∼88 °C after polymerisation with mPEG-b-PDL while the Tg of
this block (PPDL) was not detectable by DSC.25 Characteris-
ation data obtained for this copolymer confirmed the success-
ful synthesis and purification of the desired triblock
copolymer (ABC type).
Synthesis and characterisation of mPEG-b-PCL
The synthetic route to produce mPEG-b-PCL is shown in
Scheme 1C and the experimental details with characterisation
results are reported in Table 1. The target molar mass for
mPEG-b-PCL was aimed to be similar to that of mPEG-b-PDL
(i.e. 10 kDa), in order to carry out the appropriate comparison
of this well-established copolymer with novel block copolymers
of δ-decalactone. Copolymer mPEG-b-PCL was characterised by
NMR and by SEC (Fig. S16 and S17†). The peak positions in
NMR matched prior data30 and integrals suggested an approxi-
mate molar mass of 10 kDa.
Determination of CMC of PDL and PCL block copolymer
micelles
The CMC values of PDL-b-PEG-b-PDL, mPEG-b-PDL, mPEG-b-
PCL and mPEG-b-PDL-b-PPDL were determined by changes in
the I1 and I3 peak intensity ratio of pyrene with polymer con-
centration. The obtained curve was fitted using nonlinear
regression (sigmoidal, 4PL, X axis log scale) to determine the
CMC value (Fig. S18†). The inflection point (IC50) of the sig-
moidal curve was considered as the CMC value of the polymer.
Paper Polymer Chemistry
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The CMC values observed for block copolymers are pres-
ented in Table 2. Further, 95%-confidence intervals of the
CMCs were plotted to visualise any statistical diﬀerence in
obtained CMC values (Fig. 1). The CMC ranges for the PDL
block copolymers were overlapped indicating no statistically
significant diﬀerences across these materials. The CMC value
observed for mPEG-b-PCL copolymer was very close to the pre-
viously reported value,31 and was approximately 2.5 times
higher compared to the PDL block copolymer micelles (Fig. 1,
Table 2).
Preparation and characterisation of empty micelles,
nanoemulsions and NR loaded micelles
The nano-precipitation method has previously been employed
successfully for the incorporation of hydrophobic molecules
inside micellar cores32 and therefore was chosen for prepa-
ration of empty and dye loaded micelles. The recoveries (after
filtration) of micellar suspensions fabricated from mPEG-b-
PDL, mPEG-b-PCL and PDL-b-PEG-b-PDL copolymer ranged
from 90 to 95%. However, the recovery of the micellar suspen-
sions of mPEG-b-PDL-b-PPDL copolymer was approximately
60%. The sizes (Z-average diameter) recorded for samples in
HPLC grade water are reported in Table 2. The average sizes of
mPEG-b-PCL copolymer micelles corresponded well with the
sizes of similar copolymers reported in the literature.33 Size
and polydispersity indices obtained for empty mPEG-b-PCL
micelles were comparable to those of mPEG-b-PDL micelles.
Size distribution curves observed for mPEG-b-PDL and mPEG-
b-PCL micelles were unimodal whereas micelles prepared from
PDL-b-PEG-b-PDL gave bimodal distribution curves (Fig. 2).
Micelles prepared from mPEG-b-PDL-b-PPDL copolymer gave
the broadest size distribution when compared to the other
PDL block copolymers (Fig. 2).
The nano-precipitated polymers were also imaged by TEM
and it was found that the micelles obtained from amphiphilic
block copolymers were roughly spherical in shape. TEM
images of mPEG-b-PDL-b-PPDL indicated a broad size range in
the sample whereas mPEG-b-PDL and mPEG-b-PCL possessed
narrower and more uniform size distributions (Fig. 2). TEM
images of the sample PDL-b-PEG-b-PDL indicated the presence
Table 2 Characterization data of empty and loaded polymeric micelles prepared from block copolymers of PDL and PCL. (CMC – critical micelles
concentration, NA – Not applicable, SD – Standard deviation, d/nm – diameter in nanometer, mv –millivolt, wt% – weight percent)
Sample
CMC
(µg mL−1)
Z-Average size
(d/nm) (±SD)
(empty)
Poly(dispersity)
index (empty)
Zeta potential
(mv) (±SD)
(empty)
Z-Average size
(d/nm) (±SD)
(NR loaded)
Poly(dispersity)
index (NR loaded)
NR content in
micelles (wt%)
(±SD)
Propargyl PDLa NA 149 ± 4 0.04 ± 0.02 −70.5 ± 3.0 NA NA NA
PDL-b-PEG-b-PDL 1.50 163 ± 7 0.26 ± 0.03 −6.8 ± 2.6 58 ± 5 0.32 ± 0.02 0.81 ± 0.01
mPEG-b-PDL 1.33 34 ± 4 0.12 ± 0.02 −3.1 ± 0.8 38 ± 3 0.17 ± 0.02 0.69 ± 0.01
mPEG-b-PDL-b-PPDL 1.19 85 ± 5 0.28 ± 0.01 −2.5 ± 0.8 83 ± 4 0.38 ± 0.02 0.71 ± 0.01
mPEG-b-PCL 3.34 36 ± 3 0.14 ± 0.02 −1.2 ± 1.2 NA NA NA
aNano-emulsion preparation of homopolymer.
Fig. 1 Comparison of 95% conﬁdence intervals of the CMC values of synthesised copolymers. Values were obtained using non-linear curve ﬁtting
(sigmoidal, 4PL).
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of some aggregates (clusters) of the micelles. Thus, it is likely
that the bimodal distribution observed in the DLS analysis for
this sample was due, at least in part, to some clustered
micelles. Analysis (Image J) of TEM images suggested that
none of the micelles were larger than 60 nm for mPEG-b-PDL
and 80 nm for mPEG-b-PCL samples respectively. However,
as expected PDL-b-PEG-b-PDL and mPEG-b-PDL-b-PPDL
samples were shown to be larger by TEM image analysis in
accord with the DLS data. The nano-emulsion prepared from
propargyl-PDL homopolymer were also larger than the
micelles prepared from the amphiphilic diblock co-polymers
(Fig. S19†).
The zeta potentials for the nano-emulsion (globules) pre-
pared from PDL homopolymer in HEPES buﬀer (10 mM, pH
7.4) were (−) 70.5 ± 3.0 mv, which suggested charge stabilis-
ation due most likely to carboxyl termini from lower molar
mass polymers at the surface (Table 2, Fig. S19†). The zeta
potential values for amphiphilic block copolymers were close
to neutral (Table 2, Fig. S20†), as expected owing to the neutral
PEG corona for these types of micelles.34
The self-assembly behaviour of the PDL block copolymer
micelles and their ability to act as carrier vehicles was evalu-
ated by using NR as an encapsulant. The absorption maxima
of NR are strongly dependent on the polarity of the surround-
ing environment. Generally the λmax of NR shifts from a high
value to low value with a decrease in the polarity of surround-
ing media.35 A clear hypsochromic shift in λmax (i.e. 531 nm) of
NR encapsulated in micelles was observed when compared
with the maximum absorption of dye in acetone solution
(λmax – 541 nm) (Fig. S21†). This result suggested the encapsu-
lation of NR inside the hydrophobic PDL core of the
micelles.18
The amount of NR encapsulated in each micelle formu-
lation was calculated using UV-Vis spectroscopy. A control
sample (water only) showed no solubilisation of NR as antici-
pated from the highly hydrophobic character of this dye
(Fig. S22†). The loading percentages were compared using a
one-way ANOVA with Tukey’s correction for multiple compari-
sons. Loading of NR was however, low, with less than 1% dye
content in all the formulations (Table 2). The sizes of the NR
loaded micelles were not significantly diﬀerent when com-
pared to the blank micelles except with PDL-b-PEG-b-PDL
micelles (Table 2, Fig. S22†).
Preparation and characterisation of AmpB loaded micelles
The aliphatic nature of the PDL backbone suggested that
drugs with more flexible carbon chains might be better
encapsulated in the micellar cores than the highly aromatic
dye NR. Therefore, the anti-fungal compound AmpB was used
as a probe drug for PDL co-polymer formulations. AmpB-
loaded micelles were prepared by nanoprecipitation from
methanol.
It was observed that the mPEG-b-PCL copolymer, due to its
poor solubility in methanol, produced large particles on nano-
precipitation (Fig. S23-A†), although particles above 220 nm
sizes could be removed by filtration (Fig. S23-B†).
Fig. 2 Size distribution curve by intensity determined by DLS, TEM images and size distribution histogram (analysed using ImageJ software) of
empty (A) mPEG-b-PDL, (B) PDL-b-PEG-b-PDL, (C) mPEG-b-PDL-b-PPDL and (D) mPEG-b-PCL micelles. Arrows represents the presence of clusters
in PDL-b-PEG-b-PDL micelles sample. TEM images were acquired without staining the samples. Scale bar – 200 nm.
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The recovery of micellar suspensions after filtration was
approximately 30–40% for mPEG-b-PCL copolymer whereas
90–95% of mPEG-b-PDL micellar suspensions were recovered.
No significant diﬀerences in the sizes of empty micelles were
observed when compared with micelles prepared using
acetone as solvent. Furthermore, AmpB loading did not signifi-
cantly change the size of the micelles when compared with
blank micelles (Table 3, Fig. 3 and S24†). However, a high
polydispersity index was observed for mPEG-b-PCL micelles,
possibly due to the presence of aggregates (Fig. S24†).
Interestingly, after loading of AmpB in mPEG-b-PCL micelles,
a slight reduction in mean size and polydispersity index was
observed.
Zeta potentials observed for all micelle formulations in
10 mM HEPES buﬀer were almost neutral and no significant
change in zeta potential was observed after AmpB loading
(Table 3). TEM images of blank and AmpB loaded micelles
confirmed the size ranges and suggested that the prepared
micelles were roughly spherical in shape (Fig. 3 and S24†).
The AmpB content found in mPEG-b-PDL micelles (3.5 ±
0.2 wt%) was seven-fold higher than mPEG-b-PCL micelles
(0.5 ± 0.1 wt%) (Fig. 4).
In vitro release study of AmpB from block copolymer micelles
AmpB is poorly soluble in water and hence Tween 80 (1% v/v)
was added to enhance its solubility in the release media. The
concentration of Tween 80 used was well above the CMC and
hence it was expected that micelles of this surfactant would
not diﬀuse through the dialysis bag (MWCO 3.5–5 kDa). Due
to the poor loading of AmpB in mPEG-b-PCL micelles, this for-
mulation was excluded from the release study. The release
pattern of mPEG-b-PDL micelles was compared with the Tween
80 micelles formulation.
An initial burst release of AmpB (30% approx. within 6 h)
was observed with mPEG-b-PDL micelles followed by a slow-
release phase, which continued for 8 days. In contrast, control
“A” (Tween 80 micelles only) released 100% of AmpB in 3 days,
of which 53% of the drug was released in the first 6 h. The
control “B” formulation contained AmpB in Tween 80, added
to unloaded mPEG-b-PDL micelles showed a more sustained
release of AmpB compared to control “A” but faster release
compared to AmpB pre-loaded in mPEG-b-PDL micelles
(Fig. 5). In the first 6 h, no significant diﬀerence in the percen-
tage drug released was observed with control “B” when com-
pared to control “A”. However, due to the likely equilibration
of AmpB in to empty mPEG-b-PDL micelles with time, a sus-
tained release was observed with control “B”, which lasted for
5 days.
In vitro degradation study of mPEG-b-PDL micelles
The degradation time of a polyester is an important parameter
regarding its fate inside the body and/or on long term
storage in solution. A known degradation profile of a polymer
is also valuable in designing a sustained drug release
system. Therefore, a preliminary study of the hydrolytic degra-
dation of mPEG-b-PDL micelles was performed over a 4 month
period.
Samples were analysed by SEC to determine the change in
molar mass (Mn). An SEC trace of mPEG-b-PDL micelles after
120 days (at pH 7.4) and the loss of Mn versus time are shown
Table 3 Characterisation data of micelles prepared by nano-precipi-
tation method using methanol as an organic solvent. (d/nm – diameter
in nanometer, SD – standard deviation, mv –millivolt)
Sample
Z-Average
size (d/nm)
(±SD)
Polydispersity
index
Zeta
potential
(mv) (±SD)
mPEG-b-PDL (blank) 41 ± 2 0.15 ± 0.01 −2.4 ± 1.3
mPEG-b-PDL (loaded) 44 ± 3 0.16 ± 0.02 −2.8 ± 1.1
mPEG-b-PCL (blank) 36 ± 2 0.30 ± 0.03 −0.3 ± 1.7
mPEG-b-PCL (loaded) 32 ± 3 0.26 ± 0.02 −1.2 ± 1.0
Fig. 3 Size distributions curve by intensity of (A) blank mPEG-b-PDL,
(B) AmpB loaded mPEG-b-PDL, and TEM image of (C) blank mPEG-b-
PDL and (D) AmpB loaded mPEG-b-PDL micelles. The images were
taken without staining. Scale bar – 500 nm.
Fig. 4 Graph represents AmpB content (weight% to polymer) observed
in micelles, which was determined by UV-Vis spectrophotometry (λmax –
405 nm). Dots represent separate individual value and bar represents the
mean value (n = 3).
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in Fig. S25† and Fig. 6 respectively. The change in Mn of
mPEG-b-PDL (peak 1 in Fig. S25†) was used to plot the degra-
dation of polymer with time. Complete cleavage of ester frag-
ments from the non-degradable mPEG block (Mn detected for
mPEG by SEC was 10.8 kDa) was observed in 53 days at pH 4.0.
However, at physiological pH (i.e. 7.4) only a 16% drop in Mn
was observed after 4 months.
Eﬀect of PDL-based co-polymers on metabolic activity of
human cells in vitro
The potential for cytotoxicity of empty co-polymer micelles was
tested on HCT116 cells. Cells were incubated with polymers
for 24 h before their metabolic activity (as a proxy for viability)
was assessed using an Alamar Blue assay (Fig. 7).
At the highest polymer concentration no diﬀerences in via-
bility between micelles was observed. However, a small but
statistically significant reduction in viability was observed for
both co-polymers compared to untreated controls (one-way
ANOVA P ≥ 0.0001). As the maximum observed reduction in
viability was not greater than 20% the micelles were con-
sidered to display an acceptably low level of toxicity.
Discussion
In this manuscript, the synthesis of homopolymers and co-
polymers of δ-decalactone under mild conditions has been
demonstrated, with a view to developing a ‘green’ route to bio-
medical materials. We modified a previously reported pro-
cedure and observed that reactions at low temperatures gave
higher conversion, but also that no further reaction occurred
after ∼91% conversion: these results were analogous to those
reported by Martello et al.21
PDL homopolymers were prepared to evaluate the diﬀer-
ence in physicochemical properties compared to copolymers
of PDL. Although not of major significance for our particular
study, we noted that during the synthesis of homo- and block
copolymers of δ-decalactone, the formation of PDL homopoly-
mer was also always observed. This suggested the presence of
an initiator, additional to the added PEG or alcohol in the
reaction mixture. NMR spectra of δ-decalactone showed reson-
ances at 3.6 and 4.9 ppm, even from pristine samples, indicat-
ing the existence of the open form of the lactone ring and
short oligomers with hydroxyl end groups (Fig. S1† inset). We
were not able to remove all traces of these species during the
purification procedure for the monomer, and thus it is poss-
ible that the free hydroxyl groups on the oligomers could have
acted as ROP initiators. Additionally in the mechanism of TBD
catalysis for ROP proposed by Pratt et al.36 there is a reversible
step in which an alcohol is generated, and this hydroxyl group
can potentially act as initiator for other molecules activated by
TBD. Jaﬀredo et al. used TBD as catalyst as well as initiator for
Fig. 5 Cumulative release (%) of AmpB from diﬀerent test formulations
in water containing Tween 80 (1% v/v) at 37 °C. The release study was
performed by a dialysis method and AmpB concentration was estimated
using UV-Vis spectrophotometer. Curve ﬁts were based on a two-phase
decay model to accommodate the initial burst period and subsequent
sustained release.
Fig. 6 Loss in molar mass (Mn) of mPEG-b-PDL micelles with time,
incubated at 37 °C at two diﬀerent pH. The SEC instrument was calibrated
using polystyrene standards and chloroform was used as mobile phase.
Fig. 7 Eﬀects of empty micelle formulations on metabolic activity of
HCT116 measured using an Alamar Blue assay after 24 hours. N = 6;
mean ± SEM.
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the ROP of β-butyrolactone37 and suggested that TBD has the
potential to act as an initiator.
Fortunately for our study, we found that the diﬀerence in
solubility of copolymers and homo-polymers in ether oﬀered a
route to separate the desired copolymer from the homopoly-
mer impurity. However, we were not able to separate the end-
functional BZD-PDL and propargyl-PDL away from the
hydroxyl-tipped variants due to lack in solubility diﬀerences.
Therefore, the Mn values for these polymers reported from
NMR included a systematic error owing to the presence of
both detectable (BZD, propargyl) and non-detectable
(hydroxyl) initiating groups in each polymer sample. In con-
trast, the Mn values derived from SEC for the PEG-based block
copolymers were much larger than the molar masses calcu-
lated by 1H NMR. This we attribute to the very diﬀerent solu-
tion properties of the blocks compared to the polystyrene
standards, and interaction of PEG with the SEC columns
(PLgel Mixed-D). It should be noted that the Mn of mPEG
under the SEC conditions used for the copolymers was almost
twice the molar mass reported by the supplier (PEG4000 Mn ∼
7.7 kDa, mPEG5000 Mn ∼ 10.8 kDa, confirmed by 1H NMR ana-
lysis of both PEG starting materials), indicative of the obvious
limitations of polystyrene as an SEC standard for block co-
polymers.
DSC data for the copolymers suggested semicrystalline poly-
mers had been produced since both Tg and Tm were observed
for the PDL copolymers. Subsequently, the syntheses of ABC
block copolymers of ω-pentadecalactone were performed with
the aim to generate materials with better solubility and inter-
mediate crystallinity. ROP of ω-pentadecalactone using mPEG-
b-PDL as an initiator and TBD (1 mol% to monomer) as cata-
lyst was first attempted at 110 °C in bulk. During this reaction,
it was found that at higher temperature, the mPEG-b-PDL
chain was cleaved and the decalactone ring was regenerated.
The depolymerisation (reversible) process observed with PDL
was likely associated with the thermodynamic equilibrium of
δ-decalactone with TBD at high temperature.21 Therefore, in
order to provide comparator block copolymers of PEG-PDL
with PPDL, a lipase was used as catalyst to synthesise the
blocks with minimal side reactions. The molar mass of the
PPDL block was varied in attempts to modulate the solubility
of the final copolymer in acetone. It was found that increases
in the PPDL block molar mass above 2 kDa for the mPEG-b-
PDL-b-PPDL copolymer reduced its apparent solubility in
acetone. Therefore, a copolymer containing less than 2 kDa of
PPDL block was synthesised.
The organic catalyst TBD has been reported to be very
eﬃcient for the ROP of ε-caprolactone30 and therefore was
used for the synthesis of a ‘control’ copolymer of PEG and
ε-caprolactone. Compared to the ROP of δ-decalactone, no
polymer synthesis from additional initiator was observed
during ROP of ε-caprolactone with TBD as catalyst, most likely
due to the greater purity of the monomer. Other characteris-
ation data for these polymers were in line with prior literature.
Further evaluation of the PDL-based block co-polymers by
CMC measurements showed some diﬀerences in solution be-
haviour compared to previously reported block copolymers of
PCL. It is well established that the CMCs of amphiphilic block
copolymers decrease with increase in the length of core
forming block or by a decrease in the length of the shell
forming section.38 From the molar masses calculated by 1H
NMR, the relative hydrophobicities of the block copolymers
based on core- and shell-forming block lengths were predicted
to be mPEG-b-PDL < PDL-b-PEG-b-PDL < mPEG-b-PDL-b-PPDL.
However, no significant diﬀerences in the CMCs were observed
across these polymer formulations, suggesting that the diﬀer-
ences in the lengths of the hydrophobic chains in each case
were not suﬃcient to alter the self-assembly energetics to a
measurable extent. In addition, the CMC for the PDL-b-PEG-b-
PDL triblock copolymer was higher than that for mPEG-b-PDL
copolymer (Table 2). This unexpected result may have been
due to the altered packing in the triblock copolymer, with the
reduced interfacial curvature possible compared to a di-block,
and thus the reduced tendency to assemble into a well-defined
micellar architecture.
CMC values for the block copolymers of PDL were lower
compared to those determined for the PEG-b-PCL block co-
polymer. These data were also unanticipated given previous
reports which showed that PEG-b-ε-PDL copolymers exhibited
higher CMC values compared with PEG-b-PCL block co-poly-
mers, as a result of the semicrystalline hydrophobic cores in
PCL blocks compared to the amorphous ε-PDL segments.22
However, the lower CMC values for the δ-PDL copolymer
micelles in our study compared to the similar molar mass PCL
block copolymer might partly be attributed to the diﬀerent
alkyl side chain within the δ-PDL structure and a resulting
change in packing compared to the ε-PDL reported previously.
A similar phenomenon has been noted in which copolymers
of poly(lactide) and alkyl chain-substituted lactide monomer
displayed lower CMC values compared to their unsubstituted
analogues18 In addition, the CMC value of the mPEG-b-PCL
co-polymer in this study was ∼3 fold lower than that reported
by Glavas et al.22 for a PEG-b-PCL di-block. This suggested that
crystallinity of the hydrophobic block was less important than
block chain length in this instance, as the molar mass of the
hydrophobic block in our PEG-b-PCL was almost 2.5 times
higher in that in the previous work.22 It should also be noted
that the PEG chains in the work by Glavas et al. were shorter
(2 kDa) than those in this study (5 kDa), which would also
have changed the micelle structure and stability.
Low CMC values are a prerequisite for avoiding premature
release of loaded therapeutic agents from carrier systems
before reaching target sites,39 thus the PDL block copolymers
from this study were considered suitable for drug incorpor-
ation and release experiments. Micelle-like nanoparticles of
mPEG-b-PDL and mPEG-b-PCL micelles formed by nanopreci-
pitation routes were of similar sizes (∼40 nm), whereas the
sizes of ABA (PDL-b-PEG-b-PDL) and ABC (mPEG-b-PDL-b-
PPDL) tri-block copolymers were considerably larger
(85–165 nm). The bimodal size distributions observed with the
empty ABA type copolymer (PDL-b-PEG-b-PDL) micelles were
probably due to additional hydrophobic–hydrophobic inter-
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actions between micelle cores, which led to aggregation and
clustering40 This mechanism is in accord with proposals that
ABA type block copolymers can assemble in flower-shaped
micelles41 leading to a decrease in PEG chain length at the per-
iphery separating the core from the surrounding aqueous
environment. In addition, the PDL-b-PEG-b-PDL copolymer
was synthesised using a shorter chain PEG (Mn = 4.0 kDa) com-
pared to the di-block (mPEG-b-PCL and mPEG-b-PDL) co-poly-
mers and hence was expected to have a less dense hydrophilic
corona. Since PEG imparts steric stability to micelles by mini-
mizing the interfacial free energy of the micellar core and by
inhibiting hydrophobic inter-micellar attractions,42 it is likely
that hydrophobic block self-association may have occurred
with the ABA triblock copolymer micelles. In turn, partial self-
association may have generated bimodal size distributions,
which is apparent in DLS and TEM images. A similar phenom-
enon was reported earlier with PCL-b-PEG-b-PCL micelles in
which the presence of aggregates (clusters) was proposed.43
Broad size distributions were also observed for the mPEG-b-
PDL-b-PPDL tri-blocks after nanoprecipitation (Fig. 2D). Since
diﬀerent sized particles in pharmaceutical formulations for
injection would give unpredictable in vivo bio-distribution and
aggregates would lead to severe problems in elimination,44 the
tri-block co-polymers were not selected for drug incorporation
experiments in this particular study. However, since ABC tri-
block polymers have the possibility to be diﬀerentially functio-
nalised at each end, one might envisage the use of tri-blocks,
similar to those we prepared, for targeted polymersome prepa-
ration. In such cases, the diﬀerent hydrophilic blocks might
be derivatised with ligands such that combined receptor tar-
geting could be achieved. Targeted triblock polymersomes
have been shown to deliver siRNA45 but as the focus for our
study was more towards hydrophobic core polymers and
drugs, we did not pursue these tri-blocks further.
It was anticipated that the presence of alkyl side-chains
pendant to the backbone in the mPEG-b-PDL copolymer might
enhance association with aliphatic-rich drug compounds such
as AmpB. The mPEG-b-PDL copolymer formed micelles from
methanol nanoprecipitations which were of comparable size
(∼40 nm) to micelles prepared using acetone as solvent.
However, methanol was found not to be suitable for nano-
precipitation of comparator mPEG-b-PCL di-blocks, due to the
poor solubility of this copolymer. Large and polydisperse
mPEG-b-PCL micelles were formed from this solvent, but a
reduction in size and polydispersity was observed for the same
di-blocks nano-precipitated in the presence of AmpB. This may
have been due to hydrophobic interactions between the PCL
core and AmpB, which facilitated the assembly of denser
micelles. Similar results have been reported with mPEG-b-PCL
micelles when the highly hydrophobic drug fenofibrate was
loaded.46
The encapsulation data suggested that the mPEG-b-PDL
copolymer incorporated more of the AmpB drug compared to
mPEG-b-PCL copolymer. However, the drug content observed
in mPEG-b-PDL micelles was low compared to previously
reported AmpB formulations.47 This may have been associated
with the relative hydrophobicities in the polymer cores used
but may simply have been a consequence of unoptimised
experimental conditions during the nanoprecipitation reac-
tions. For example, it has been reported that the loading of
AmpB in a polymeric drug delivery system can be improved by
either increase in the hydrophobic block length or by initial
quantity of drug used for loading or both.48 In addition, com-
putational simulation of nanoprecipitation processes49 using
models of poly(glyceryl adipate) esters and amphiphilic drugs
has shown a marked eﬀect of polymer collapse rate on drug
incorporation, and this is highly solvent dependent. It is thus
reasonable to assume that the diﬀerence in drug loading we
observed in mPEG-b-PDL polymers compared to previous
materials could be due to both solvent quality and polymer
composition.
An in vitro release experiment of AmpB loaded micelles
indicated that reversible binding of drug towards carrier
(micelles) was important in defining the release profile, based
on the partition coeﬃcient of drug between carrier and dis-
persed phase.50 Nevertheless, the release pattern observed
with novel mPEG-b-PDL micelles was more sustained com-
pared to the earlier reported release pattern for AmpB in PLA
nanoparticles using the same release media.29
Preliminary in vitro degradation studies suggested that the
mPEG-b-PDL micelles degraded more slowly at physiological
pH (9% after 30 days) compared to two diﬀerent reports on
PEG-b-PLA block copolymers (27.6%,51 16.3%52 after 30 days).
This was likely due to the higher hydrophobicity of mPEG-b-
PDL copolymer. However, it was found that the degradation
rate was faster than with mPEG-b-PCL copolymers (9.0% after
126 days,53 4.1% after 56 days54). It has been reported that
amorphous polymers degrade faster than semicrystalline poly-
mers55 and thus the faster degradation of the PDL block com-
pared to the PCL blocks in our study may have been due to
diﬀerences in crystallinity.
The in vitro cell activity study results suggested that the
mPEG-b-PDL micelles were similar to mPEG-b-PCL compara-
tors in regards to their eﬀects on metabolic activity. The
similar cyto-compatibility profile was not unexpected, as in
both systems the cells encountered primarily the PEG corona
and degradation of the PDL and PCL cores was not significant
over the assay period.
Conclusions
In this study, the synthesis and characterisation of homopoly-
mers and novel amphiphilic block copolymers based on
renewable monomers has been reported. The self-assembly of
amphiphilic block copolymers was demonstrated via NR
loading. Further, increased loading of AmpB was demon-
strated with mPEG-b-PDL micelles compared to their counter-
part mPEG-b-PCL micelles. In vitro release studies showed a
prolonged release of AmpB from mPEG-b-PDL micelles when
compared with Tween 80 micelles. Preliminary in vitro degra-
dation studies of mPEG-b-PDL micelles indicated the slow
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degradation of copolymer at physiological pH. In vitro cell
metabolic activity assays revealed that the novel mPEG-b-PDL
micelles exhibited similar tolerability profiles compared to
mPEG-b-PCL micelles. The results suggest that mPEG-b-PDL
copolymers might find future application as drug delivery
systems in which slow release and long degradation time is
required, for example in sub-cutaneously injected depot
formulations.
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